日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.

血管内皮生长因子与受体的相互作用是小鼠肝纤维化发生的先决条件

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin D J, Wu Y, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Masaki T, Fukui H

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

血管内皮生长因子和血管生成素-1通过募集血管生成干细胞和造血干细胞来刺激出生后造血

Hattori K, Dias S, Heissig B, Hackett N R, Lyden D, Tateno M, Hicklin D J, Zhu Z, Witte L, Crystal R G, Moore M A, Rafii S

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

抑制旁分泌和自分泌 VEGF/VEGFR-2 信号通路对于诱导异种移植人类白血病的长期缓解至关重要。

Dias, S; Hattori, K; Heissig, B; Zhu, Z; Wu, Y; Witte, L; Hicklin, D J; Tateno, M; Bohlen, P; Moore, M A; Rafii, S

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.

VEGFR-2 的自分泌刺激可激活人类白血病细胞的生长和迁移

Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin D J, Witte L, Moore M A, Rafii S

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

恶性黑色素瘤中HLA I类抗原加工分子的下调:与疾病进展的关联

Kageshita, T; Hirai, S; Ono, T; Hicklin, D J; Ferrone, S

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma

β2-微球蛋白突变、HLA I类抗原丢失和黑色素瘤的肿瘤进展

Hicklin, D J; Wang, Z; Arienti, F; Rivoltini, L; Parmiani, G; Ferrone, S